Bone Biologics Corp (BBLG) Form 10-Q Quarterly Reports
Bone Biologics Corp (BBLG) is a publicly traded company on the Nasdaq, categorized under SIC 3842 (Orthopedic, Prosthetic & Surgical Appliances & Supplies). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: BBLG
CIK: 1419554
Exchange: Nasdaq
SIC 3842: Orthopedic, Prosthetic & Surgical Appliances & Supplies
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Weinberg & Company, P.A.
Auditor SinceSince 12/31/2017 12:00:00 AM
Lead Engagement PartnerJohn Lucas
Audit LocationLos Angeles, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 25-NSE | 2026-10-13 | — | 25-NSE Filing | 0001354457-26-000978 | View SEC Doc Filr Page |
| 4 | 2026-09-30 | 2026-09-28 | 4 | 0001493152-26-045149 | View SEC Doc Filr Page |
| 4 | 2026-09-30 | 2026-09-28 | 4 | 0001493152-26-045147 | View SEC Doc Filr Page |
| 4 | 2026-09-30 | 2026-09-28 | 4 | 0001493152-26-045140 | View SEC Doc Filr Page |
| 4 | 2026-09-30 | 2026-09-28 | 4 | 0001493152-26-045135 | View SEC Doc Filr Page |
| 8-K | 2026-09-29 | 2026-09-28 | 8-K | 0001493152-26-044889 | View SEC Doc Filr Page |
| 8-K | 2026-09-16 | 2026-09-10 | 8-K | 0001493152-26-042940 | View SEC Doc Filr Page |
| DEF 14A | 2026-08-28 | 2026-08-28 | DEF 14A | 0001493152-26-040640 | View SEC Doc Filr Page |
| PRE 14A | 2026-08-18 | 2026-08-18 | PRE 14A | 0001493152-26-039034 | View SEC Doc Filr Page |
| 10-Q | 2026-08-14 | 2026-06-30 | 10-Q | 0001493152-26-038482 | View SEC Doc Filr Page |
| EFFECT | 2026-07-24 | — | EFFECT Filing | 9999999995-26-002449 | View SEC Doc Filr Page |
| 424B3 | 2026-07-24 | — | 424B3 | 0001493152-26-034605 | View SEC Doc Filr Page |
| 8-K | 2026-07-23 | 2026-07-23 | 8-K | 0001493152-26-034334 | View SEC Doc Filr Page |
| DEFA14A | 2026-07-20 | — | DEFA14A | 0001493152-26-033938 | View SEC Doc Filr Page |
| S-3 | 2026-07-17 | — | S-3 | 0001493152-26-033789 | View SEC Doc Filr Page |
| 8-K | 2026-07-16 | 2026-07-15 | 8-K | 0001493152-26-033586 | View SEC Doc Filr Page |
| 8-K | 2026-07-09 | 2026-07-07 | 8-K | 0001493152-26-032694 | View SEC Doc Filr Page |
| ARS | 2026-07-02 | 2025-12-31 | ARS | 0001493152-26-031654 | View SEC Doc Filr Page |
| DEFA14A | 2026-07-02 | — | DEFA14A | 0001493152-26-031653 | View SEC Doc Filr Page |
| DEF 14A | 2026-07-02 | 2026-07-02 | DEF 14A | 0001493152-26-031652 | View SEC Doc Filr Page |
| 10-Q | 2026-05-14 | 2026-03-31 | 10-Q | 0001493152-26-023163 | View SEC Doc Filr Page |
| 8-K | 2026-03-13 | 2026-03-13 | 8-K | 0001493152-26-010080 | View SEC Doc Filr Page |
| 424B5 | 2026-03-13 | — | 424B5 | 0001493152-26-010072 | View SEC Doc Filr Page |
| 10-K | 2026-03-02 | 2025-12-31 | 10-K | 0001493152-26-008564 | View SEC Doc Filr Page |
| 4 | 2026-01-21 | 2026-01-08 | 4 | 0001493152-26-003103 | View SEC Doc Filr Page |